526 related articles for article (PubMed ID: 17166339)
1. Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?
Jacobs A; Preston IR; Gomberg-Maitland M
Curr Med Res Opin; 2006 Dec; 22(12):2567-74. PubMed ID: 17166339
[TBL] [Abstract][Full Text] [Related]
2. The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies.
Davie NJ; Schermuly RT; Weissmann N; Grimminger F; Ghofrani HA
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():38-49. PubMed ID: 19335746
[TBL] [Abstract][Full Text] [Related]
3. Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.
Opitz CF; Ewert R
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():1-9. PubMed ID: 16919004
[TBL] [Abstract][Full Text] [Related]
4. Endothelin receptor antagonists in pulmonary arterial hypertension.
Dupuis J; Hoeper MM
Eur Respir J; 2008 Feb; 31(2):407-15. PubMed ID: 18238950
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor antagonists in pulmonary arterial hypertension.
Channick RN; Sitbon O; Barst RJ; Manes A; Rubin LJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):62S-67S. PubMed ID: 15194180
[TBL] [Abstract][Full Text] [Related]
6. A review of sitaxsentan sodium in patients with pulmonary arterial hypertension.
Waxman AB
Vasc Health Risk Manag; 2007; 3(1):151-7. PubMed ID: 17583185
[TBL] [Abstract][Full Text] [Related]
7. Endothelin receptor blockade in the management of pulmonary arterial hypertension: selective and dual antagonism.
Trow TK; Taichman DB
Respir Med; 2009 Jul; 103(7):951-62. PubMed ID: 19304472
[TBL] [Abstract][Full Text] [Related]
8. The endothelin system in pulmonary arterial hypertension.
Galié N; Manes A; Branzi A
Cardiovasc Res; 2004 Feb; 61(2):227-37. PubMed ID: 14736539
[TBL] [Abstract][Full Text] [Related]
9. Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.
Abman SH
Annu Rev Med; 2009; 60():13-23. PubMed ID: 18764741
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?
Opitz CF; Ewert R; Kirch W; Pittrow D
Eur Heart J; 2008 Aug; 29(16):1936-48. PubMed ID: 18562303
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor antagonists in preclinical models of pulmonary hypertension.
Pullamsetti SS; Schermuly RT
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():3-13. PubMed ID: 19335741
[TBL] [Abstract][Full Text] [Related]
12. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.
Neuhofer W; Pittrow D
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():50-67. PubMed ID: 19335747
[TBL] [Abstract][Full Text] [Related]
13. Endothelin receptor antagonism: role in the treatment of pulmonary arterial hypertension related to scleroderma.
Kabunga P; Coghlan G
Drugs; 2008; 68(12):1635-45. PubMed ID: 18681488
[TBL] [Abstract][Full Text] [Related]
14. Endothelin receptor antagonists.
Motte S; McEntee K; Naeije R
Pharmacol Ther; 2006 Jun; 110(3):386-414. PubMed ID: 16219361
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of pulmonary arterial hypertension by endothelin receptor antagonists in 2008].
Cacoub P; Amoura Z; Langleben D
Rev Med Interne; 2008 Apr; 29(4):283-9. PubMed ID: 18243424
[TBL] [Abstract][Full Text] [Related]
16. Endothelin receptor antagonists for pulmonary arterial hypertension: rationale and place in therapy.
Price LC; Howard LS
Am J Cardiovasc Drugs; 2008; 8(3):171-85. PubMed ID: 18533738
[TBL] [Abstract][Full Text] [Related]
17. [Endothelin receptor antagonists in pulmonary arterial hypertension].
Tokgöz HC; Can MM; Kaymaz C
Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():9-15. PubMed ID: 20819750
[TBL] [Abstract][Full Text] [Related]
18. Sitaxsentan sodium for pulmonary hypertension.
MacIntyre IM; Dhaun N; Goddard J; Webb DJ
Drugs Today (Barc); 2008 Aug; 44(8):585-600. PubMed ID: 18846270
[TBL] [Abstract][Full Text] [Related]
19. Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension.
Horn EM; Widlitz AC; Barst RJ
Expert Opin Investig Drugs; 2004 Nov; 13(11):1483-92. PubMed ID: 15500395
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension.
Fox B; Langleben D; Hirsch AM; Schlesinger RD; Eisenberg MJ; Joyal D; Blenkhorn F; Lesenko L
Can J Cardiol; 2013 Jun; 29(6):672-7. PubMed ID: 22819360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
